InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Berkenblit Anna, Vice-Présidente Senior et Directrice Médicale. Officer active across 1 company, notably ImmunoGen, Inc.. Aggregated, 4 reports have been logged. Activity tracked since 30 June 2021. The latest transaction was filed on 31 December 2021 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
1,761 shares@ US$5.6047.6% of flowCommon StockSEC:0001179110-22-000106
1,761 shares@ US$5.6023.8% of flowCommon StockSEC:0001179110-22-000106:0
2,062 shares@ US$5.5226.2% of flowCommon StockSEC:0001179110-21-007318:0
2,062 shares@ US$5.5252.4% of flowCommon StockSEC:0001179110-21-007318
4 of 4 declarations
About Berkenblit Anna
Anna Berkenblit is the Senior Vice President and Chief Medical Officer at ImmunoGen, Inc. She oversees the medical and scientific activities of the company, ensuring alignment with strategic objectives. Her expertise is crucial for the development of new treatments.
